Actively Recruiting

Age: 18Years - 85Years
All Genders
ID06867120

Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study

Led by Peking Union Medical College Hospital · Updated on 2026-04-06

352

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

P

Peking Union Medical College Hospital

Lead Sponsor

B

Beijing Sixth Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a new way to predict severe acute pancreatitis (SAP) early in patients diagnosed with acute pancreatitis (AP). This study aims to monitor bowel sounds continuously to identify those likely to develop SAP, which has a poor prognosis. It is a prospective, multi-center study including patients newly diagnosed with AP at emergency departments across three centers starting from December 2023. Participants will undergo continuous bowel sound monitoring for at least 48 hours using standardized equipment. The bowel sounds will be analyzed by an automated algorithm to estimate an activity index that may indicate the risk of SAP. This monitoring is blinded to the patients' SAP status. The study also explores differences in gut microbiota and blood markers related to intestinal permeability between patients with and without SAP. During the study, researchers will track the occurrence of SAP within 7 days after enrollment as the primary outcome. They will also observe mortality, length of hospital stay, and organ failure up to 30 days. Participants will have their bowel sounds monitored continuously, and samples for gut microbiota and blood markers will be collected. This study helps assess intestinal function in AP patients and may improve early prognosis prediction. The total participation time varies based on hospitalization duration and monitoring needs.

CONDITIONS

Brief Title

Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged between 18 and 85 years old
  • Diagnosed with acute pancreatitis by meeting at least two of the following: characteristic abdominal pain, serum amylase and lipase levels over three times normal, or typical abdominal imaging
  • Acute pancreatitis onset within 48 hours
  • Patient or family understands and agrees to the study by signing informed consent
Not Eligible

You will not qualify if you...

  • Serious conditions requiring surgery or abdominal lavage
  • Pregnant women
  • History of muscle or nerve disorders, chronic pancreatitis, inflammatory bowel disease, cancer, or irritable bowel syndrome
  • Severe digestive, respiratory, cardiovascular, blood, endocrine, psychiatric, or infectious diseases
  • History of abdominal surgery except appendectomy or cholecystectomy
  • Allergy to silicone, polycarbonate materials, or medical plaster

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 7 days after enrollment

Participants diagnosed with acute pancreatitis are observed to assess the severity of their condition during hospitalization.

Daily assessments during hospitalization

Long-term Monitoring

Duration - Up to 30 days after enrollment

Participants are followed up for 30 days after enrollment to monitor outcomes such as mortality and length of hospital stay.

Follow-up visits or contacts as needed within 30 days

Trial Site Locations

Total: 1 location

1

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China, 100000

Actively Recruiting

Loading map...

Research Team

Z

Ziying Han, Doctor of Medicine

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Multicenter Clinical Study on AI-Powered Precision Decisio...

Pancreatic Cancer

Actively Recruiting

1 location

A Randomized Controlled Trial Evaluating Fluid Resuscitation...

Acute Pancreatitis (AP)

Actively Recruiting

1 location

Randomized, Double-blind Clinical Trial on the Efficacy and ...

Acute Pancreatitis

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here